{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:12:32Z","timestamp":1787796752618,"version":"build-2784847793"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Izmir Institute of Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tay-Sachs disease is a rare lysosomal storage disorder caused by \u03b2-Hexosaminidase A enzyme deficiency causing abnormal GM2 ganglioside accumulation in the central nervous system. GM2 accumulation triggers chronic neuroinflammation due to neurodegeneration-based astrogliosis and macrophage activity with the increased expression level of\n                    <jats:italic>Ccl2<\/jats:italic>\n                    in the cortex of a recently generated Tay-Sachs disease mouse model\n                    <jats:italic>Hexa-\/-Neu3-\/-<\/jats:italic>\n                    . Propagermanium blocks the neuroinflammatory response induced by Ccl2, which is highly expressed in astrocytes and microglia. The ketogenic diet has broad potential usage in neurological disorders, but the knowledge of the impact on Tay-Sach disease is limited. This study aimed to display the effect of combining the ketogenic diet and propagermanium treatment on chronic neuroinflammation in the Tay-Sachs disease mouse model.\n                    <jats:italic>Hexa-\/-Neu3-\/-<\/jats:italic>\n                    mice were placed into the following groups: (i) standard diet, (ii) ketogenic diet, (iii) standard diet with propagermanium, and (iv) ketogenic diet with propagermanium. RT-PCR and immunohistochemistry analyzed neuroinflammation markers. Behavioral analyses were also applied to assess phenotypic improvement. Notably, the expression levels of neuroinflammation-related genes were reduced in the cortex of 140-day-old\n                    <jats:italic>Hexa-\/-Neu3-\/-<\/jats:italic>\n                    mice compared to \u03b2-Hexosaminidase A deficient mice (\n                    <jats:italic>Hexa-\/-<\/jats:italic>\n                    ) after combined treatment. Immunohistochemical analysis displayed correlated results with the RT-PCR. Our data suggest the potential to implement combined treatment to reduce chronic inflammation in Tay-Sachs and other lysosomal storage diseases.\n                  <\/jats:p>","DOI":"10.1007\/s11011-025-01553-6","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T02:17:30Z","timestamp":1740709050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Combined treatment of Ketogenic diet and propagermanium reduces neuroinflammation in Tay-Sachs disease mouse model"],"prefix":"10.1007","volume":"40","author":[{"given":"Orhan Kerim","family":"Inci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0243-5011","authenticated-orcid":false,"given":"Volkan","family":"Seyrantepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"issue":"1","key":"1553_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10545-013-9613-3","volume":"37","author":"LD Archer","year":"2014","unstructured":"Archer LD, Langford-Smith KJ, Bigger BW, Fildes JE (2014) Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation, and adaptive immunity. J Inherit Metab Dis 37(1):1\u201312. https:\/\/doi.org\/10.1007\/s10545-013-9613-3","journal-title":"J Inherit Metab Dis"},{"key":"1553_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3389\/fnins.2015.00417","volume":"9","author":"ME Bosch","year":"2015","unstructured":"Bosch ME, Kielian T (2015) Neuroinflammatory paradigms in lysosomal storage diseases. Front NeuroSci 9:417. https:\/\/doi.org\/10.3389\/fnins.2015.00417","journal-title":"Front NeuroSci"},{"key":"1553_CR3","doi-asserted-by":"publisher","first-page":"104614","DOI":"10.1016\/j.neuint.2019.104614","volume":"133","author":"L Camberos-Luna","year":"2020","unstructured":"Camberos-Luna L, Massieu L (2020) Therapeutic strategies for ketosis induction and their potential efficacy for the treatment of acute brain injury and neurodegenerative diseases. Neurochem Int 133:104614. https:\/\/doi.org\/10.1016\/j.neuint.2019.104614","journal-title":"Neurochem Int"},{"key":"1553_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1742-2094-11-132","volume":"11","author":"J Cazareth","year":"2014","unstructured":"Cazareth J, Guyon A, Heurteaux C, Chabry J, Petit-Paitel A (2014) Molecular and cellular neuroinflammatory status of mouse brain after systemic lipopolysaccharide challenge: the importance of CCR2\/CCL2 signaling. J Neuroinflamm 11:132. https:\/\/doi.org\/10.1186\/1742-2094-11-132","journal-title":"J Neuroinflamm"},{"issue":"1","key":"1553_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10545-013-9610-6","volume":"37","author":"SM Cologna","year":"2014","unstructured":"Cologna SM, Cluzeau CV, Yanjanin NM, Blank PS, Dail MK, Siebel S, Toth CL, Wassif CA, Lieberman AP, Porter FD (2014) Human and mouse neuroinflammation markers in Niemann-pick disease, type C1. J Inherit Metab Dis 37(1):83\u201392. https:\/\/doi.org\/10.1007\/s10545-013-9610-6","journal-title":"J Inherit Metab Dis"},{"key":"1553_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O (2017) Microglia function in the Central Nervous System during Health and Neurodegeneration. Annu Rev Immunol 35:441\u2013468. https:\/\/doi.org\/10.1146\/annurev-immunol-051116-052358","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"1553_CR7","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1093\/hmg\/ddy112","volume":"27","author":"A Cougnoux","year":"2018","unstructured":"Cougnoux A, Drummond RA, Collar AL, Iben JR, Salman A, Westgarth H, Wassif CA, Cawley NX, Farhat NY, Ozato K, Lionakis MS, Porter FD (2018) Microglia activation in Niemann-pick disease, type C1, is amendable to therapeutic intervention. Hum Mol Genet 27(12):2076\u20132089. https:\/\/doi.org\/10.1093\/hmg\/ddy112","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1553_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12974-019-1672-4","volume":"16","author":"A Cougnoux","year":"2019","unstructured":"Cougnoux A, Drummond RA, Fellmeth M, Navid F, Collar AL, Iben J, Kulkarni AB, Pickel J, Schiffmann R, Wassif CA, Cawley NX, Lionakis MS, Porter FD (2019) Unique molecular signature in mucolipidosis type IV microglia. J Neuroinflamm 16(1):276. https:\/\/doi.org\/10.1186\/s12974-019-1672-4","journal-title":"J Neuroinflamm"},{"issue":"1","key":"1553_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12974-020-01947-6","volume":"17","author":"SA Demir","year":"2020","unstructured":"Demir SA, Timur ZK, Ate\u015f N, Mart\u00ednez LA, Seyrantepe V (2020) GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early-onset Tay-Sachs disease. J Neuroinflamm 17(1):277. https:\/\/doi.org\/10.1186\/s12974-020-01947-6","journal-title":"J Neuroinflamm"},{"issue":"6","key":"1553_CR10","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1111\/j.1471-4159.2010.06733.x","volume":"113","author":"CA Denny","year":"2010","unstructured":"Denny CA, Heinecke KA, Kim YP, Baek RC, Loh KS, Butters TD, Bronson RT, Platt FM, Seyfried TN (2010) A restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult sandhoff disease mice. J Neurochem 113(6):1525\u20131535. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06733.x","journal-title":"J Neurochem"},{"issue":"35","key":"1553_CR11","doi-asserted-by":"publisher","first-page":"E2334","DOI":"10.1073\/pnas.1209577109","volume":"109","author":"C Di Malta","year":"2012","unstructured":"Di Malta C, Fryer JD, Settembre C, Ballabio A (2012) Astrocyte dysfunction triggers neurodegeneration in a lysosomal storage disorder. Proc Natl Acad Sci USA 109(35):E2334\u2013E2342. https:\/\/doi.org\/10.1073\/pnas.1209577109","journal-title":"Proc Natl Acad Sci USA"},{"key":"1553_CR12","doi-asserted-by":"publisher","first-page":"147798","DOI":"10.1016\/j.brainres.2022.147798","volume":"1780","author":"L Francelle","year":"2022","unstructured":"Francelle L, Mazzulli JR (2022) Neuroinflammation in Gaucher disease, neuronal ceroid lipofuscinosis, and commonalities with Parkinson\u2019s disease. Brain Res 1780:147798. https:\/\/doi.org\/10.1016\/j.brainres.2022.147798","journal-title":"Brain Res"},{"issue":"1\u20132","key":"1553_CR13","doi-asserted-by":"publisher","first-page":"108537","DOI":"10.1016\/j.ymgme.2024.108537","volume":"143","author":"Z Fyke","year":"2024","unstructured":"Fyke Z, Johansson R, Scott AI, Wiley D, Chelsky D, Zak JD, Nakouzi A, Koster N, K. P., Yoshii A (2024) Reduction of neuroinflammation and seizures in a mouse model of CLN1 batten disease using the small molecule enzyme mimetic N-Tert-butyl hydroxylamine. Mol Genet Metab 143(1\u20132):108537. https:\/\/doi.org\/10.1016\/j.ymgme.2024.108537","journal-title":"Mol Genet Metab"},{"issue":"7","key":"1553_CR14","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.3390\/ijms23073485","volume":"23","author":"H Geng","year":"2022","unstructured":"Geng H, Chen L, Tang J, Chen Y, Wang L (2022) The role of CCL2\/CCR2 Axis in Cerebral Ischemia-Reperfusion Injury and Treatment: from animal experiments to clinical trials. Int J Mol Sci 23(7):3485. https:\/\/doi.org\/10.3390\/ijms23073485","journal-title":"Int J Mol Sci"},{"key":"1553_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neuint.2019.02.010","volume":"125","author":"S He","year":"2019","unstructured":"He S, Liu R, Li B, Huang L, Fan W, Tembachako CR, Zheng X, Xiong X, Miyata M, Xu B, Li Y, Fang W (2019) Propagermanium, a CCR2 inhibitor, attenuates cerebral ischemia\/reperfusion injury by inhibiting inflammatory responses induced by microglia. Neurochem Int 125:99\u2013110. https:\/\/doi.org\/10.1016\/j.neuint.2019.02.010","journal-title":"Neurochem Int"},{"key":"1553_CR16","doi-asserted-by":"publisher","first-page":"100723","DOI":"10.1016\/j.ymgmr.2021.100723","volume":"27","author":"A H\u00f6ller","year":"2021","unstructured":"H\u00f6ller A, Albrecht U, Baumgartner Sigl S, Z\u00f6ggeler T, Ramoser G, Bernar B, Karall D, Scholl-B\u00fcrgi S (2021) Successful implementation of classical ketogenic dietary therapy in a patient with Niemann-pick disease type C. Mol Genet Metabolism Rep 27:100723. https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100723","journal-title":"Mol Genet Metabolism Rep"},{"issue":"4","key":"1553_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3346\/jkms.2006.21.4.733","volume":"21","author":"YB Hong","year":"2006","unstructured":"Hong YB, Kim EY, Jung SC (2006) Upregulation of proinflammatory cytokines in the fetal brain of the Gaucher mouse. J Korean Med Sci 21(4):733\u2013738. https:\/\/doi.org\/10.3346\/jkms.2006.21.4.733","journal-title":"J Korean Med Sci"},{"key":"1553_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.omtm.2022.04.001","volume":"25","author":"Y Horii","year":"2022","unstructured":"Horii Y, Iniwa T, Onitsuka M, Tsukimoto J, Tanaka Y, Ike H, Fukushi Y, Ando H, Takeuchi Y, Nishioka SI, Tsuji D, Ikuo M, Yamazaki N, Takiguchi Y, Ishimaru N, Itoh K (2022) Reversal of neuroinflammation in novel GS model mice by single i.c.v. administration of CHO-derived rhCTSA precursor protein. Molecular therapy. Methods Clin Dev 25:297\u2013310. https:\/\/doi.org\/10.1016\/j.omtm.2022.04.001","journal-title":"Methods Clin Dev"},{"issue":"1","key":"1553_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/ijms25010124","volume":"25","author":"J Jang","year":"2023","unstructured":"Jang J, Kim SR, Lee JE, Lee S, Son HJ, Choe W, Yoon KS, Kim SS, Yeo EJ, Kang I (2023) Molecular mechanisms of Neuroprotection by Ketone Bodies and Ketogenic Diet in Cerebral Ischemia and neurodegenerative diseases. Int J Mol Sci 25(1):124. https:\/\/doi.org\/10.3390\/ijms25010124","journal-title":"Int J Mol Sci"},{"issue":"22","key":"1553_CR20","doi-asserted-by":"publisher","first-page":"8767","DOI":"10.3390\/ijms21228767","volume":"21","author":"NJ Jensen","year":"2020","unstructured":"Jensen NJ, Wodschow HZ, Nilsson M, Rungby J (2020) Effects of Ketone bodies on Brain metabolism and function in neurodegenerative diseases. Int J Mol Sci 21(22):8767. https:\/\/doi.org\/10.3390\/ijms21228767","journal-title":"Int J Mol Sci"},{"issue":"Pt 4","key":"1553_CR21","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/brain\/awg089","volume":"126","author":"M Jeyakumar","year":"2003","unstructured":"Jeyakumar M, Thomas R, Elliot-Smith E, Smith DA, van der Spoel AC, d\u2019Azzo A, Perry VH, Butters TD, Dwek RA, Platt FM (2003) Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain 126(Pt 4):974\u2013987. https:\/\/doi.org\/10.1093\/brain\/awg089","journal-title":"Brain"},{"issue":"1","key":"1553_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2006.08.041","volume":"1128","author":"YV Kalkonde","year":"2007","unstructured":"Kalkonde YV, Morgan WW, Sigala J, Maffi SK, Condello C, Kuziel W, Ahuja SS, Ahuja SK (2007) Chemokines in the MPTP model of Parkinson\u2019s disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration. Brain Res 1128(1):1\u201311. https:\/\/doi.org\/10.1016\/j.brainres.2006.08.041","journal-title":"Brain Res"},{"issue":"17","key":"1553_CR23","doi-asserted-by":"publisher","first-page":"11457","DOI":"10.1128\/JVI.79.17.11457-11466.2005","volume":"79","author":"RS Klein","year":"2005","unstructured":"Klein RS, Lin E, Zhang B, Luster AD, Tollett J, Samuel MA, Engle M, Diamond MS (2005) Neuronal CXCL10 directs CD8\u2009+\u2009T-cell recruitment and control of West Nile virus encephalitis. J Virol 79(17):11457\u201311466. https:\/\/doi.org\/10.1128\/JVI.79.17.11457-11466.2005","journal-title":"J Virol"},{"issue":"2","key":"1553_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/WCO.0b013e3283515e4a","volume":"25","author":"EH Kossoff","year":"2012","unstructured":"Kossoff EH, Hartman AL (2012) Ketogenic diets: new advances for metabolism-based therapies. Curr Opin Neurol 25(2):173\u2013178. https:\/\/doi.org\/10.1097\/WCO.0b013e3283515e4a","journal-title":"Curr Opin Neurol"},{"issue":"17","key":"1553_CR25","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.3390\/ijms21176213","volume":"21","author":"AF Leal","year":"2020","unstructured":"Leal AF, Benincore-Fl\u00f3rez E, Solano-Galarza D, Garz\u00f3n Jaramillo RG, Echeverri-Pe\u00f1a OY, Suarez DA, Alm\u00e9ciga-D\u00edaz CJ, Espejo-Mojica AJ (2020) GM2 Gangliosidoses: clinical features, pathophysiological aspects, and current therapies. Int J Mol Sci 21(17):6213. https:\/\/doi.org\/10.3390\/ijms21176213","journal-title":"Int J Mol Sci"},{"key":"1553_CR26","doi-asserted-by":"publisher","first-page":"101900","DOI":"10.1016\/j.arr.2023.101900","volume":"87","author":"W Lei","year":"2023","unstructured":"Lei W, Jia L, Wang Z, Liang Z, Zhao A, Liu Y, Tian Y, Zhao L, Chen Y, Shi G, Yang Z, Yang Y, Xu X (2023) CC chemokines family in fibrosis and aging: from mechanisms to therapy. Ageing Res Rev 87:101900. https:\/\/doi.org\/10.1016\/j.arr.2023.101900","journal-title":"Ageing Res Rev"},{"issue":"7638","key":"1553_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, M\u00fcnch AE, Chung WS, Peterson TC, Wilton DK, Frouin A, Napier BA, Panicker N, Kumar M, Buckwalter MS, Rowitch DH, Dawson VL, Dawson TM, Stevens B, Barres BA (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541(7638):481\u2013487. https:\/\/doi.org\/10.1038\/nature21029","journal-title":"Nature"},{"issue":"10","key":"1553_CR28","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1182\/blood-2007-11-125039","volume":"111","author":"TT Murooka","year":"2008","unstructured":"Murooka TT, Rahbar R, Platanias LC, Fish EN (2008) CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR\/4E-BP1. Blood 111(10):4892\u20134901. https:\/\/doi.org\/10.1182\/blood-2007-11-125039","journal-title":"Blood"},{"issue":"1\u20132","key":"1553_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ymgme.2022.06.001","volume":"137","author":"MI Nilsson","year":"2022","unstructured":"Nilsson MI, Crozier M, Di Carlo A, Xhuti D, Manta K, Roik LJ, Bujak AL, Nederveen JP, Tarnopolsky MG, Hettinga B, Meena NK, Raben N, Tarnopolsky MA (2022) Nutritional co-therapy with 1,3-butanediol and multi-ingredient antioxidants enhances autophagic clearance in pompe disease. Mol Genet Metab 137(1\u20132):228\u2013240. https:\/\/doi.org\/10.1016\/j.ymgme.2022.06.001","journal-title":"Mol Genet Metab"},{"key":"1553_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.nbd.2018.07.014","volume":"118","author":"Y Ogawa","year":"2018","unstructured":"Ogawa Y, Furusawa E, Saitoh T, Sugimoto H, Omori T, Shimizu S, Kondo H, Yamazaki M, Sakuraba H, Oishi K (2018) Inhibition of astrocytic adenosine receptor A2A attenuates microglial activation in a mouse model of sandhoff disease. Neurobiol Dis 118:142\u2013154. https:\/\/doi.org\/10.1016\/j.nbd.2018.07.014","journal-title":"Neurobiol Dis"},{"key":"1553_CR31","doi-asserted-by":"publisher","unstructured":"Pan X, Caillon A, Fan S, Khan S, Tomatsu S, Pshezhetsky AV (2024) Heterologous HSPC transplantation rescues neuroinflammation and ameliorates peripheral manifestations in the mouse model of lysosomal transmembrane enzyme deficiency, MPS IIIC. Cells, 13(10), 877. https:\/\/doi.org\/10.3390\/cells13100877","DOI":"10.3390\/cells13100877"},{"issue":"4","key":"1553_CR32","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3390\/biomedicines11041067","volume":"11","author":"MK Pandey","year":"2023","unstructured":"Pandey MK (2023) Exploring pro-inflammatory immunological mediators: unraveling the mechanisms of Neuroinflammation in lysosomal Storage diseases. Biomedicines 11(4):1067. https:\/\/doi.org\/10.3390\/biomedicines11041067","journal-title":"Biomedicines"},{"key":"1553_CR33","doi-asserted-by":"publisher","unstructured":"Ramesh G, MacLean AG, Philipp MT (2013) Cytokines and chemokines are at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators of inflammation 2013:480739. https:\/\/doi.org\/10.1155\/2013\/480739","DOI":"10.1155\/2013\/480739"},{"issue":"11","key":"1553_CR34","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1161\/ATVBAHA.109.193268","volume":"29","author":"CA Reichel","year":"2009","unstructured":"Reichel CA, Rehberg M, Lerchenberger M, Berberich N, Bihari P, Khandoga AG, Zahler S, Krombach F (2009) Ccl2 and Ccl3 mediate neutrophil recruitment via induction of protein synthesis and generation of lipid mediators. Arterioscler Thromb Vasc Biol 29(11):1787\u20131793. https:\/\/doi.org\/10.1161\/ATVBAHA.109.193268","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"25","key":"1553_CR35","doi-asserted-by":"publisher","first-page":"10195","DOI":"10.1523\/JNEUROSCI.0822-13.2013","volume":"33","author":"K Sandhoff","year":"2013","unstructured":"Sandhoff K, Harzer K (2013) Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis. J Neuroscience: Official J Soc Neurosci 33(25):10195\u201310208. https:\/\/doi.org\/10.1523\/JNEUROSCI.0822-13.2013","journal-title":"J Neuroscience: Official J Soc Neurosci"},{"issue":"2","key":"1553_CR36","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ng1095-170","volume":"11","author":"K Sango","year":"1995","unstructured":"Sango K, Yamanaka S, Hoffmann A, Okuda Y, Grinberg A, Westphal H, McDonald MP, Crawley JN, Sandhoff K, Suzuki K, Proia RL (1995) Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat Genet 11(2):170\u2013176. https:\/\/doi.org\/10.1038\/ng1095-170","journal-title":"Nat Genet"},{"issue":"Pt A","key":"1553_CR37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.expneurol.2017.09.012","volume":"299","author":"V Seyrantepe","year":"2018","unstructured":"Seyrantepe V, Demir SA, Timur ZK, Von Gerichten J, Marsching C, Erdemli E, Oztas E, Takahashi K, Yamaguchi K, Ates N, D\u00f6nmez Demir B, Dalkara T, Erich K, Hopf C, Sandhoff R, Miyagi T (2018) Murine sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease. Experimental Neurol 299(Pt A) 26\u201341. https:\/\/doi.org\/10.1016\/j.expneurol.2017.09.012","journal-title":"Experimental Neurol"},{"key":"1553_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fphar.2012.00059","volume":"3","author":"CE Stafstrom","year":"2012","unstructured":"Stafstrom CE, Rho JM (2012) The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol 3:59. https:\/\/doi.org\/10.3389\/fphar.2012.00059","journal-title":"Front Pharmacol"},{"issue":"1","key":"1553_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00401-019-01985-2","volume":"138","author":"SK Stumpf","year":"2019","unstructured":"Stumpf SK, Berghoff SA, Trevisiol A, Spieth L, D\u00fcking T, Schneider LV, Schlaphoff L, Dreha-Kulaczewski S, Bley A, Burfeind D, Kusch K, Mitkovski M, Ruhwedel T, Guder P, R\u00f6hse H, Denecke J, G\u00e4rtner J, M\u00f6bius W, Nave KA, Saher G (2019) Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus-Merzbacher disease. Acta Neuropathol 138(1):147\u2013161. https:\/\/doi.org\/10.1007\/s00401-019-01985-2","journal-title":"Acta Neuropathol"},{"key":"1553_CR40","doi-asserted-by":"publisher","first-page":"136195","DOI":"10.1016\/j.neulet.2021.136195","volume":"764","author":"C Toro","year":"2021","unstructured":"Toro C, Zainab M, Tifft CJ (2021) The GM2 gangliosidoses: unlocking the mysteries of pathogenesis and treatment. Neurosci Lett 764:136195. https:\/\/doi.org\/10.1016\/j.neulet.2021.136195","journal-title":"Neurosci Lett"},{"issue":"2","key":"1553_CR41","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.bbrc.2011.04.142","volume":"409","author":"K Tsukuda","year":"2011","unstructured":"Tsukuda K, Mogi M, Iwanami J, Min LJ, Jing F, Oshima K, Horiuchi M (2011) Irbesartan attenuates ischemic brain damage by inhibition of MCP-1\/CCR2 signaling pathway beyond AT\u2081 receptor blockade. Biochem Biophys Res Commun 409(2):275\u2013279. https:\/\/doi.org\/10.1016\/j.bbrc.2011.04.142","journal-title":"Biochem Biophys Res Commun"},{"issue":"27","key":"1553_CR42","doi-asserted-by":"publisher","first-page":"20423","DOI":"10.1074\/jbc.R110.134452","volume":"285","author":"EB Vitner","year":"2010","unstructured":"Vitner EB, Platt FM, Futerman AH (2010) Common and uncommon pathogenic cascades in lysosomal storage diseases. J Biol Chem 285(27):20423\u201320427. https:\/\/doi.org\/10.1074\/jbc.R110.134452","journal-title":"J Biol Chem"},{"issue":"Pt 6","key":"1553_CR43","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/brain\/aws095","volume":"135","author":"EB Vitner","year":"2012","unstructured":"Vitner EB, Farfel-Becker T, Eilam R, Biton I, Futerman AH (2012) Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher\u2019s disease. Brain 135(Pt 6):1724\u20131735. https:\/\/doi.org\/10.1093\/brain\/aws095","journal-title":"Brain"},{"key":"1553_CR44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bbr.2017.05.066","volume":"332","author":"J Xu","year":"2017","unstructured":"Xu J, Dong H, Qian Q, Zhang X, Wang Y, Jin W, Qian Y (2017) Astrocyte-derived CCL2 participates in surgery-induced cognitive dysfunction and neuroinflammation via evoking microglia activation. Behav Brain Res 332:145\u2013153. https:\/\/doi.org\/10.1016\/j.bbr.2017.05.066","journal-title":"Behav Brain Res"},{"issue":"2","key":"1553_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12031-010-9336-y","volume":"42","author":"X Yang","year":"2010","unstructured":"Yang X, Cheng B (2010) Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity. J Mol Neuroscience: MN 42(2):145\u2013153. https:\/\/doi.org\/10.1007\/s12031-010-9336-y","journal-title":"J Mol Neuroscience: MN"},{"issue":"3","key":"1553_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1750-3639.2010.00445.x","volume":"21","author":"G Yang","year":"2011","unstructured":"Yang G, Meng Y, Li W, Yong Y, Fan Z, Ding H, Wei Y, Luo J, Ke ZJ (2011) Neuronal MCP-1 mediates microglia recruitment and neurodegeneration induced by the mild impairment of oxidative metabolism. Brain Pathol 21(3):279\u2013297. https:\/\/doi.org\/10.1111\/j.1750-3639.2010.00445.x","journal-title":"Brain Pathol"},{"issue":"4","key":"1553_CR47","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00018-013-1459-1","volume":"71","author":"Y Yao","year":"2014","unstructured":"Yao Y, Tsirka SE (2014) Monocyte chemoattractant protein-1 and the blood-brain barrier. Cell Mol Life Sci 71(4):683\u2013697. https:\/\/doi.org\/10.1007\/s00018-013-1459-1","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"1553_CR48","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/107999001750277862","volume":"21","author":"S Yokochi","year":"2001","unstructured":"Yokochi S, Hashimoto H, Ishiwata Y, Shimokawa H, Haino M, Terashima Y, Matsushima K (2001) An anti-inflammatory drug, propagermanium, may target GPI-anchored proteins associated with an MCP-1 receptor, CCR2. J Interferon Cytokine Research: Official J Int Soc Interferon Cytokine Res 21(6):389\u2013398. https:\/\/doi.org\/10.1089\/107999001750277862","journal-title":"J Interferon Cytokine Research: Official J Int Soc Interferon Cytokine Res"},{"issue":"1","key":"1553_CR49","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1038\/s41598-018-20052-6","volume":"8","author":"FPS Yu","year":"2018","unstructured":"Yu FPS, Dworski S, Medin JA (2018) Deletion of MCP-1 impedes pathogenesis of Acid Ceramidase Deficiency. Sci Rep 8(1):1808. https:\/\/doi.org\/10.1038\/s41598-018-20052-6","journal-title":"Sci Rep"},{"issue":"1","key":"1553_CR50","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11064-012-0913-z","volume":"38","author":"S Zaheer","year":"2013","unstructured":"Zaheer S, Thangavel R, Wu Y, Khan MM, Kempuraj D, Zaheer A (2013) Enhanced expression of glia maturation factor correlates with glial activation in the brain of triple transgenic Alzheimer\u2019s disease mice. Neurochem Res 38(1):218\u2013225. https:\/\/doi.org\/10.1007\/s11064-012-0913-z","journal-title":"Neurochem Res"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01553-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-025-01553-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01553-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T15:40:16Z","timestamp":1743090016000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-025-01553-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["1553"],"URL":"https:\/\/doi.org\/10.1007\/s11011-025-01553-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3899681\/v1","asserted-by":"object"}]},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"26 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Ethical approval (No: 002-2018) was obtained by the ethics committee of the Izmir Inst\u0131tute of Technology, Izmir, Turkey.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}